KDR and neoplasm: The observation of frequent endothelial cell VEGFR2 immunoreactivity and differences in immunoreactivity of VEGFR2 in tumor cells between pulmonary ADC and SCC during our multi-tumor screening analyses led us to further investigate VEGFR2 expression on a larger, independent cohort of NSCLC tissues.